Imudon tab for the races. 40 pc

Description

Composition
Active substance:
Imudon® (bacterial lysates mixture) – 2.7 mg (on dry substance): including lysates of bacteria: [L. acidophilus + L. delbrueckii ss lactis + L. helveticus + L. fermentum + S. pyogenes groupe A + S. sanguis groupe H + S. aureus + E. faecium + E. faecalis + K. pneumoniae ss pneumoniae + F. nucleatum ss fusiforme + C. pseudodiphtheriticum + C. albicans] -0,1575 mg excipients: glycine – 2.0 mg sodium deoxycholate – 0.53 mg thiomersal – not more than 0.0125 mg.
Excipients:
Glycine – 47.3 mg, lactose monohydrate – 350 mg Mannitol – 100 mg Sodium saccharinate – 1.12 mg, povidone – 10.0 mg Sodium bicarbonate – 30.0 mg anhydrous citric acid – 23.0 mg mint flavor – 8.0 mg magnesium stearate – 4.88 mg.
Product form:
To 8 tablets in blisters (blister) made of composite material Polyamide / aluminum / PVC and aluminum foil printed patent. Three or five contour of cellular packages (blisters) 8 tablets together with instructions for use placed in a pile of cardboard.
Contraindications
– increased individual sensitivity to the drug or its components; – Children under 3 years of age; – autoimmune diseases.
Dosage
2.7 mg
Indications
Treatment and prevention of infectious and inflammatory diseases of the oral cavity and pharynx:
pharyngitis and chronic tonsillitis; preoperative and postoperative period after tonsillectomy; superficial and deep periodontal disease, periodontitis, stomatitis (including aphthous), glossitis; erythematous and ulcerative gingivitis; dysbacteriosis oral cavity; infection after tooth extraction, implantation of artificial tooth roots; ulceration caused by dentures ;.
Interaction with other drugs
The interaction with other drugs is not registered. Imudon® can be used with drugs other groups.
pharmachologic effect
Pharmacological group:
Immunostimulatory agent. ATX code [L03AX].
Pharmacological properties:
Immunostimulatory bacterial drug for local application in ENT, dentistry. Activates phagocytosis, increases the amount of immunocompetent cells, and enhances the interferon production of lysozyme and imunnoglobulina A in saliva.
Pregnancy and breast-feeding
Information on the use Imudon in pregnant women is not enough. Relevant data from animal experiments and epidemiological studies are not available. Do not take Imudon® during pregnancy or lactation.
Conditions of supply of pharmacies
Without recipe.
side effects
In rare cases the use may be accompanied by allergic reactions (rash, urticaria, angioneurotic edema), reactions of the gastrointestinal (nausea, vomiting, abdominal pain), fever, exacerbation of asthma, cough. In very rare cases, the use of the drug may lead to the development of erythema nodosum, hemorrhagic vasculitis, thrombocytopenia.
Impact on the ability to drive a car and other mechanisms: No evidence of the need for any restrictions on the activities associated with the management of a car or other mechanisms during treatment.
special instructions
Children 3 to 6 years old resolves tablets under mandatory supervision of adults! It should not take food and water, and rinse the mouth for one hour after the drug Imudon® not to lower the therapeutic efficacy of the drug. When administering the drug to patients who observe a salt-free or salted diet, it is necessary to consider that 1 Imudon® tablet contains 15 mg Na +. Patients with asthma, in which administration of drugs containing the bacterial lysates, exacerbates the disease (bronchial asthma attack), the drug is not recommended.
NOT SUITABLE FOR USE · If any of the package (blister). · When the fuzzy label. · After the end of the shelf life of the drug.
Storage conditions
Stored and transported in accordance with JV 3.3.2.1248-03 at a temperature not higher than 25 ° C. Keep out of the reach of children.
Dosing and Administration
For adults and adolescents over 14 years.
In acute inflammatory diseases of the mouth and pharynx, and exacerbation of chronic diseases drug taking 8 tablets per day. Tablets resolves (not liquid) in the oral cavity at intervals of 1 – 2 hr.
The average duration of treatment – 10 days. For oral prophylaxis of exacerbation of chronic inflammatory diseases and pharynx drug taking 6 tablets per day. Tablets resolves (not liquid) in the oral cavity at an interval of 2 hr. Course duration – 20 days. preventive treatments is recommended Imudon 3 – 4 times a year.
For children from 3 to 14 years. In the treatment of acute and exacerbation of chronic inflammatory diseases of the oral cavity and pharynx, as well as for the prevention of drug is used to 6 tablets per day. Tablets resolves (not liquid) in the oral cavity at intervals of 1 – 2 hr. The duration of treatment for acute conditions – 10 days to prevent exacerbation of chronic diseases – 20 days. prophylactic use of the course should be repeated 3 – 4 times a year.
Overdose
Imudon cases of overdose is not described.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist